Artificial insemination is a technique used primarily for treating infertility in humans. It involves surgically placing sperm near a female’s cervix or uterus for conception. This process is much less complicated than in vitro fertilization (IVF) and is effective for causes of infertility related to cervical mucus hostility or semen abnormalities.
The global artificial insemination market is estimated to be valued at US$ 10.6 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of advanced insemination technologies is driving the growth of the artificial insemination market. Earlier, artificial insemination involved basic procedures using fresh or frozen sperm. However, with technological advancements, sophisticated insemination methods such as intrauterine insemination and intracervical insemination are now being used. These methods provide better chances of conception as the sperm is placed directly into the uterus or cervical canal. They also help reduce the risk of infection and assist in overcoming problems related to hostile cervical mucus or defective sperm movement. The rising awareness about these advanced techniques and their higher success rates compared to traditional artificial insemination is propelling the artificial insemination market forward.
Segment Analysis
The global artificial insemination market is dominated by the intrauterine insemination (IUI) segment. IUI is the process of directly placing sperm inside a woman's uterus to facilitate fertilization and pregnancy. It accounts for over 65% of the market share as it is the most commonly preferred method by fertility clinicians and patients owing to its lower cost and greater chances of conception compared to in vitro fertilization. IUI offers improved odds for conception compared to timed intercourse as it places the sperm directly in the uterus rather than requiring them to travel through the cervix andFallopian tubes. This boosts the chances of fertilization occurring.
Key Takeaways
The global Artificial Insemination Market Demand is estimated to be valued at US$ 10.6 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031.
Regional analysis
North America currently dominates the global artificial insemination market due to rising infertility rates, greater acceptance of assisted reproductive technologies, and strong government support through favorable reimbursement policies. It is estimated to remain the highest revenue generating market during the forecast period. However, Asia Pacific is poised to witness the fastest growth on account of increasing healthcare expenditures, growing medical tourism industry, rising disposable incomes, and expanding patient base seeking fertility treatments.
Key players
Key players operating in the artificial insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. Pride Angel and Irvine Scientific currently dominate the market with their wide range of high-quality and FDA-approved ART devices, media, and cryopreservation solutions.
Explore more related article on this topic: https://www.newsanalyticspro.com/the-global-artificial-insemination-in-agriculture-boosts-milk/
Explore more related articles: https://whotimes.com/change-harmony-exploring-the-dynamic-world-of-ion-exchange-membranes-for-applications/
https://blogger-veritas.blogspot.com/2024/01/the-global-india-ready-to-mix-food.html
Comments
0 comment